Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 11, 2018New England Journal of MedicineOpen Access

Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

View Full Paper
Ask AI
Bookmark
Share

Authors

ENElisa NemesUniversity of Cape TownHGHennie GeldenhuysUniversity of Cape TownVRVirginie RozotUniversity of Cape Town

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nemes et al. (2018) studied this question.

synapsesocial.com/papers/6a65664a5b83bbc0ac39baafhttps://doi.org/10.1056/nejmoa1714021
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CD4 and CD8 T Cell Responses to the M. tuberculosis Ag85B-TB10.4 Promoted by Adjuvanted Subunit, Adenovector or Heterologous Prime Boost Vaccination2009 · 73 citations
  2. 2OMIP‐022: Comprehensive assessment of antigen‐specific human T‐cell functionality and memory2014 · 19 citations
  3. 3Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials2013 · 1,022 citations
  4. 4Clinical Testing of Tuberculosis Vaccine Candidates2016 · 31 citations
  5. 5Making wider use of the world's most widely used vaccine: Bacille Calmette–Guérin revaccination reconsidered2013 · 92 citations